260 results on '"Padmanabhan, Priya"'
Search Results
2. Measurement of Urinary Symptoms, Health-Related Quality of Life, and Outcomes of Treatment of Genitourinary and Pelvic Floor Disorders
3. Autologous Fascial Sling
4. Incidence of New or Worsening Overactive Bladder Among Patients with a Prior SARS-CoV-2 Infection: A Cohort Study
5. Surgical Management of Post Prostatectomy Incontinence
6. Percutaneous tibial neuromodulation initial therapy compliance and subsequent third‐line treatment patterns.
7. Monoclonal Gammopathy of Renal Significance (MGRS) - Case Series from a Tertiary Center in Kerala
8. Antibiotic use, best practice statement adherence, and UTI rate for intradetrusor onabotulinumtoxin‐A injection for overactive bladder: A multi‐institutional collaboration from the SUFU Research Network (SURN).
9. Fibrin microthrombi in bladder urothelium after SARS-CoV-2 infection: Case report
10. Maternity Leave Satisfaction Among Physicians Compared with Nonphysician Professionals.
11. Phospholipase D Inhibition by Hexanal, and Its Applications in Enhancing Shelf Life and Quality of Fruits, Vegetables and Flowers
12. Adherence to AUA Clinical Guidelines: Motivations and Barriers
13. Management of Recurrent Stress Urinary Incontinence After Failed Mid-Urethral Sling Placement
14. MP52-09 PUDENDAL NEUROMODULATION IN SPINA BIFIDA PATIENTS WITH NEUROGENIC BLADDER AND BOWEL DYSFUNCTION
15. PD05-03 BLADDER-DIRECTED VERSUS PELVIC FLOOR THERAPY IN WOMEN WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: PRELIMINARY RESULTS
16. MP37-03 RADIATION EXPOSURE DURING SACRAL NEUROMODULATION LEAD PLACEMENT: MULTI-INSTITUTIONAL DESCRIPTIVE STUDY
17. PD19-10 PROGRESSION OF OVERACTIVE BLADDER SYMPTOMS IN PATIENTS WITH PRIOR SARS-CoV-2 INFECTION
18. MP37-15 PERCUTANEOUS TIBIAL NEUROMODULATION INITIAL THERAPY COMPLIANCE AND SUBSEQUENT THIRD-LINE TREATMENT PATTERNS
19. Hexanal-Based Technologies for Phospholipase D Inhibition and Enhancement of Shelf Life and Quality in Fruits and Vegetables
20. Adherence to AUA Clinical Guidelines: Motivations and Barriers
21. Ethylene Signal Transduction During Fruit Ripening and Senescence
22. Effect of Hexanal Composition Treatment on Wine Grape Quality
23. Effect of Hexanal Vapor Treatments on Delay of Flower Senescence
24. Hexanal Effects on Greenhouse Vegetables
25. Preharvest and Postharvest Technologies Based on Hexanal
26. Benefits of Application of Hexanal Compositions on Apples
27. Improving Shelf-life and Quality of Sweet Cherry (Prunus avium L.) by Preharvest Application of Hexanal Compositions
28. Sexual Health in Elderly Women
29. Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi‐institutional collaboration from the SUFU research network
30. Iron supplementation promotes in vitro shoot induction and multiplication of Baptisia australis
31. Change in urinary storage symptoms following treatment for female stress urinary incontinence
32. Urinary Incontinence
33. PD06-05 FRACTIONAL CARBON DIOXIDE VAGINAL LASER FOR THE TREATMENT OF URINARY SYMPTOMS: 12 MONTHS RESULTS
34. PD21-08 THE INCIDENCE OF NEW OR WORSENING OAB SYMPTOMS IN PATIENTS WITH PRIOR SARS COV-2 INFECTION
35. Voiding Dysfunction after Female Anti-Incontinence Surgery
36. Software Quality Perceptions of Stakeholders Involved in the Software Development Process
37. Anatomy of Pelvic Support
38. The Non-surgical Options for SUI—Is Any One Optimal?
39. Approach to Management of Iatrogenic Foreign Bodies of the Lower Urinary Tract Following Reconstructive Pelvic Surgery
40. PD54-06 PREOPERATIVE URODYNAMIC FINDINGS ARE NOT ASSOCIATED WITH URINARY RETENTION AFTER BLADDER ONABOTULINUMTOXINA INJECTION.
41. 108 - Surgical, Radiographic, and Endoscopic Anatomy of the Female Pelvis
42. MP89-13 ONABOTULINUMTOXIN A IN PATIENTS WITH A HISTORY OF PRIOR PELVIC RADIATION THERAPY
43. PD28-11 CHANGES IN URINARY STORAGE SYMPTOMS FOLLOWING SURGICAL TREATMENT FOR FEMALE STRESS URINARY INCONTINENCE
44. A comparative transcriptomic analysis of the extremely boron tolerant plant Puccinellia distans with the moderately boron tolerant Gypsophila arrostil
45. Bladder Augmentation and the Risk of Carcinoma
46. Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity
47. Stress Urinary Incontinence in Women with Neurogenic Voiding Dysfunction
48. BOTULINUM TOXIN A: THE SHIFT TO A MINIMALLY INVASIVE MANAGEMENT OF NEUROGENIC BLADDER: MP80-14
49. THE VALUE OF RETROPUBIC SLINGS FOLLOWING FAILED PRIOR ANTI-INCONTINENCE PROCEDURES: MP38-09
50. Male incontinence: Evaluation and treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.